| 1 | 7766631 | Differential stabilization of eukaryotic DNA topoisomerase I cleavable complexes by camptothecin derivatives. | Biochemistry | 1995 May 30 |
1 |
| 2 | 8010056 | Inhibition of phosphorylation of histone H1 and H3 induced by 10-hydroxycamptothecin, DNA topoisomerase I inhibitor, in murine ascites hepatoma cells. | Zhongguo Yao Li Xue Bao | 1993 Nov |
1 |
| 3 | 8239542 | Effect of DNA topoisomerase I inhibitor, 10-hydroxycamptothecin, on the structure and function of nuclei and nuclear matrix in bladder carcinoma MBT-2 cells. | Anticancer Res | 1993 Sep-Oct |
3 |
| 4 | 9499438 | Upregulation of p21WAF1/CIP1 in human breast cancer cell lines MCF-7 and MDA-MB-468 undergoing apoptosis induced by natural product anticancer drugs 10-hydroxycamptothecin and camptothecin through p53-dependent and independent pathways. | Int J Oncol | 1998 Apr |
9 |
| 5 | 11129738 | Differential regulation of P53, c-Myc, Bcl-2, Bax and AFP protein expression, and caspase activity during 10-hydroxycamptothecin-induced apoptosis in Hep G2 cells. | Anticancer Drugs | 2000 Oct |
13 |
| 6 | 11324469 | Differentiation-inducing action of 10-hydroxycamptothecin on human hepatoma Hep G2 cells. | Acta Pharmacol Sin | 2000 Apr |
2 |
| 7 | 12518324 | Experimental therapy of human prostate cancer by inhibiting MDM2 expression with novel mixed-backbone antisense oligonucleotides: in vitro and in vivo activities and mechanisms. | Prostate | 2003 Feb 15 |
1 |
| 8 | 13130078 | Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation, apoptosis, multiple gene expression, and chemotherapy. | Proc Natl Acad Sci U S A | 2003 Sep 30 |
1 |
| 9 | 14751837 | Chemosensitization and radiosensitization of human cancer by antisense anti-MDM2 oligonucleotides: in vitro and in vivo activities and mechanisms. | Ann N Y Acad Sci | 2003 Dec |
1 |
| 10 | 16084097 | Synthesis and evaluation of a DHA and 10-hydroxycamptothecin conjugate. | Bioorg Med Chem | 2005 Oct 1 |
1 |
| 11 | 16603448 | Bcl-2 siRNA induced apoptosis and increased sensitivity to 5-fluorouracil and HCPT in HepG2 cells. | J Drug Target | 2006 Jan |
4 |
| 12 | 17439414 | siRNA-mediated Bcl-2 and Bcl-xl gene silencing sensitizes human hepatoblastoma cells to chemotherapeutic drugs. | Clin Exp Pharmacol Physiol | 2007 May-Jun |
2 |
| 13 | 17482779 | Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles. | Int J Pharm | 2007 Aug 1 |
2 |
| 14 | 18318465 | Benzyl ether-linked glucuronide derivative of 10-hydroxycamptothecin designed for selective camptothecin-based anticancer therapy. | J Med Chem | 2008 Mar 27 |
1 |
| 15 | 20810290 | Experimental evaluation of inhibitory effect of 10-hydroxycamptothecin on hypoxia-inducible factor-1α expression and angiogenesis in liver tumors after transcatheter arterial embolization. | J Vasc Interv Radiol | 2010 Oct |
7 |
| 16 | 21435100 | Hydroxycamptothecin-loaded Fe3O4 nanoparticles induce human lung cancer cell apoptosis through caspase-8 pathway activation and disrupt tight junctions. | Cancer Sci | 2011 Jun |
7 |
| 17 | 21499429 | Preparation, characterization and targeting of micronized 10-hydroxycamptothecin-loaded folate-conjugated human serum albumin nanoparticles to cancer cells. | Int J Nanomedicine | 2011 |
1 |
| 18 | 22051412 | Binding interactions of water-soluble camptothecin derivatives with bovine serum albumin. | Spectrochim Acta A Mol Biomol Spectrosc | 2012 Feb |
1 |
| 19 | 22160573 | Interaction of human serum albumin with 10-hydroxycamptothecin: spectroscopic and molecular modeling studies. | Mol Biol Rep | 2012 May |
9 |
| 20 | 22320884 | MARVELD1 inhibited cell proliferation and enhance chemosensitivity via increasing expression of p53 and p16 in hepatocellular carcinoma. | Cancer Sci | 2012 Apr |
1 |
| 21 | 23569373 | Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery. | Int J Nanomedicine | 2013 |
2 |
| 22 | 24525588 | Cyclane-aminol 10-hydroxycamptothecin analogs as novel DNA topoisomerase I inhibitors induce apoptosis selectively in tumor cells. | Anticancer Drugs | 2014 Jul |
2 |
| 23 | 24530519 | A novel multifunctional poly(amidoamine) dendrimeric delivery system with superior encapsulation capacity for targeted delivery of the chemotherapy drug 10-hydroxycamptothecin. | Int J Pharm | 2014 Apr 25 |
2 |
| 24 | 24660962 | Self-assembling peptide of D-amino acids boosts selectivity and antitumor efficacy of 10-hydroxycamptothecin. | ACS Appl Mater Interfaces | 2014 Apr 23 |
2 |
| 25 | 25207865 | Integrin α(V)β(3)-targeted magnetic nanohybrids with enhanced antitumor efficacy, cell cycle arrest ability, and encouraging anti-cell-migration activity. | ACS Appl Mater Interfaces | 2014 Oct 8 |
2 |
| 26 | 25523336 | RPL13A as a reference gene for normalizing mRNA transcription of ovarian cancer cells with paclitaxel and 10-hydroxycamptothecin treatments. | Mol Med Rep | 2015 Apr |
2 |
| 27 | 25766079 | Intracellular target delivery of 10-hydroxycamptothecin with solid lipid nanoparticles against multidrug resistance. | J Drug Target | 2015 |
6 |
| 28 | 26177829 | Role of Raf-kinase inhibitor protein in colorectal cancer and its regulation by hydroxycamptothecine. | J Biomed Sci | 2015 Jul 16 |
1 |
| 29 | 26270258 | Nanodrug Formed by Coassembly of Dual Anticancer Drugs to Inhibit Cancer Cell Drug Resistance. | ACS Appl Mater Interfaces | 2015 Sep 2 |
1 |
| 30 | 26639236 | 10-Hydroxycamptothecin induces apoptosis in human neuroblastoma SMS-KCNR cells through p53, cytochrome c and caspase 3 pathways. | Neoplasma | 2016 |
3 |
| 31 | 26744836 | The inhibitory effects of camptothecin (CPT) and its derivatives on the substrate uptakes mediated by human solute carrier transporters (SLCs). | Xenobiotica | 2016 Sep |
2 |
| 32 | 26815184 | [Effect of 10-hydroxycamptotbecine on the expression of VEGF in rheumatoid arthritis synovial fibroblasts]. | Zhonghua Yi Xue Za Zhi | 2015 Sep 15 |
3 |
| 33 | 26821653 | Effects of 10-hydroxycamptothecin on intrinsic mitochondrial pathway in silkworm BmN-SWU1 cells. | Pestic Biochem Physiol | 2016 Feb |
1 |
| 34 | 27470413 | Directional modification of chrysin for exerting apoptosis and enhancing significantly anti-cancer effects of 10-hydroxy camptothecin. | Biomed Pharmacother | 2016 Aug |
2 |
| 35 | 27655499 | Effects of 10-hydroxycamptothecin on differentiation of RAW264.7 cells into osteoclasts. | J Biol Regul Homeost Agents | 2016 Jul-Sep |
2 |
| 36 | 27721159 | Chemosensitizing effect of Paris Saponin I on Camptothecin and 10-hydroxycamptothecin in lung cancer cells via p38 MAPK, ERK, and Akt signaling pathways. | Eur J Med Chem | 2017 Jan 5 |
7 |
| 37 | 27878232 | Involvement of bleomycin hydrolase and poly(ADP-ribose) polymerase-1 in Ubc9-mediated resistance to chemotherapy agents. | Int J Oncol | 2017 Jan |
1 |
| 38 | 27912880 | Combination of baicalein and 10-hydroxy camptothecin exerts remarkable synergetic anti-cancer effects. | Phytomedicine | 2016 Dec 15 |
2 |
| 39 | 28097065 | Upregulation of NOXA by 10-Hydroxycamptothecin plays a key role in inducing fibroblasts apoptosis and reducing epidural fibrosis. | PeerJ | 2017 |
4 |
| 40 | 29406728 | Development of a Light-Controlled Nanoplatform for Direct Nuclear Delivery of Molecular and Nanoscale Materials. | J Am Chem Soc | 2018 Mar 21 |
1 |
| 41 | 29434958 | Anticancer effects of 10-hydroxycamptothecin induce apoptosis of human osteosarcoma through activating caspase-3, p53 and cytochrome <i>c</i> pathways. | Oncol Lett | 2018 Feb |
12 |
| 42 | 30221690 | Astragalus polysaccharide combined with 10-hydroxycamptothecin inhibits metastasis in non-small cell lung carcinoma cell lines via the MAP4K3/mTOR signaling pathway. | Int J Mol Med | 2018 Dec |
8 |
| 43 | 30720099 | 10‑Hydroxycamptothecin induces apoptosis in human fibroblasts by regulating miRNA‑23b‑3p expression. | Mol Med Rep | 2019 Apr |
5 |
| 44 | 31151274 | Tissue Distribution and Anti-Lung Cancer Effect of 10-Hydroxycamptothecin Combined with Platycodonis Radix and Glycyrrhizae Radix ET Rhizoma. | Molecules | 2019 May 30 |
5 |
| 45 | 31551777 | Hydroxycamptothecin Inhibits Peritendinous Adhesion <i>via</i> the Endoplasmic Reticulum Stress-Dependent Apoptosis. | Front Pharmacol | 2019 |
4 |
| 46 | 31621074 | AMPK-mTOR-ULK1 axis activation-dependent autophagy promotes hydroxycamptothecin-induced apoptosis in human bladder cancer cells. | J Cell Physiol | 2020 May |
3 |
| 47 | 31642230 | [Synergistic Effect of 2-deoxy-D-glucose Combined with Hydroxycamptothecin on Apoptosis of Breast Cancer Cells]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2019 Jul |
2 |
| 48 | 31817790 | (S)-10-Hydroxycamptothecin Inhibits Esophageal Squamous Cell Carcinoma Growth In Vitro and In Vivo Via Decreasing Topoisomerase I Enzyme Activity. | Cancers (Basel) | 2019 Dec 6 |
1 |
| 49 | 32057901 | Decreasing Arl4c expression by inhibition of AKT signal in human lung adenocarcinoma cells. | Life Sci | 2020 Apr 1 |
7 |
| 50 | 32061620 | Tumor microenvironment-activated self-recognizing nanodrug through directly tailored assembly of small-molecules for targeted synergistic chemotherapy. | J Control Release | 2020 May 10 |
3 |